Exposure of Bronchial Epithelial Cells to Whole Cigarette Smoke: Assessment of Cellular Responses

Abstract

Cigarette smoke is composed of approximately 5% particulate phase and 95% vapour phase by weight. However, routine in vitro toxicological testing of smoke normally only measures the activity of the particulate phase. This study describes a new system for exposing cells at an air–liquid interface to serial dilutions of gaseous smoke. Confluent monolayers of NCI-H292 human lung epithelial cells on semi-permeable membranes were placed in a purpose-designed Perspex chamber at an air–liquid interface. The cells were exposed to dilute whole mainstream cigarette smoke for 30 minutes, followed by a 20-hour recovery period. Firstly, high and low delivery cigarettes were compared, and cytotoxicity was determined by using the neutral red uptake assay. Clear differential cytotoxic responses were observed with the two cigarette types, which correlated positively with the concentrations of components in smoke, and particularly compounds in the vapour phase, such as aldehydes. Secondly, low doses of smoke were found to up-regulate mRNA levels of the secreted mucin, MUC5AC, and to stimulate the production of interleukin (IL)-6, IL-8 and matrix-metalloprotease-1, but had no effect on growth-related oncogene alpha. This system will facilitate further investigations into the toxicological mechanisms of cigarette smoke components, and may be useful for studying other gaseous mixtures or aerosols.

Keywords

cigarette cytotoxicity smoke vapour

Get full access to this article

View all access options for this article.

References

Keith

C.H.

, & Tesh

P.G.

(1965). Measurement of the total smoke issuing from a burning cigarette. Tobacco Science 9, 61–64.

Bombick

D.W.

, Ayres

P.H.

, & Doolittle

D. J.

(1997). Cytotoxicity assessment of whole smoke and vapour phase of mainstream and sidestream cigarette smoke from three Kentucky reference cigarettes. Toxicological Methods 7, 177–190.

Ritter

, Knebel

J.W.

, & Aufderheide

(2001). In vitro exposure of isolated cells to native gaseous compounds — development and validation of an optimized system for human lung cells. Experimental Toxicology and Pathology 53, 373–386.

Ritter

, Knebel

J.W.

, & Aufderheide

(2003). Exposure of human lung cells to inhalable substances: a novel test strategy involving clean air exposure periods using whole diluted cigarette mainstream smoke. Inhalation Toxicolology 15, 67–84.

Aufderheide

, Knebel

J.W.

, & Ritter

(2003). An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Experimental Toxicology and Pathology 55, 51–57.

Wolz

, Krause

, Scherer

, Aufderheide

, & Mohr

(2002). In vitro genotoxicity assay of sidestream smoke using a human bronchial epithelial cell line. Food and Chemical Toxicology 40, 845–850.

Jeffery

P.K.

(1998). Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53, 129–136.

Takeyama

, Jung

, Shim

J.J.

, Burgel

P.R.

, Dao-Pick

, Ueki

I.F.

, Protin

, Kroschel

, & Nadel

J.A.

(2001). Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. American Journal of Physiology — Lung Cell Molecular Physiology 28, L165–L172.

Rusznak

, Mills

P.R.

, Devalia

J.L.

, Sapsford

R.J.

, Davies

R.J.

, & Lozewicz

(2000). Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. American Journal of Physiology — Lung Cell Molecular Physiology 2, 530–536.

10.

Beisswenger

, Platz

, Seifart

, Vogelmeier

, & Bals

(2004). Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration 71, 402–409.

11.

Richter

, O'Donnell

R.A.

, Powell

R.M.

, Sanders

M.W.

, Holgate

S.T.

, Djukanovic

, & Davies

D.E.

(2002). Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. American Journal of Physiology — Lung Cell Molecular Physiology 27, 85–90.

12.

Hewson

C.A.

, Edbrooke

M.R.

, & Johnston

S.L.

(2004). PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. Journal of Molecular Biology 344, 683–695.

13.

Phillips

, Williamson

, & Massey

E.D.

(2002). A method to expose mammalian cells in vitro to whole smoke at the air–liquid interface. Mutagenesis 17, 566.

14.

Anon. (2001). Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity. NIH Publication No: 01-4500, 102 pp. Washington, DC, USA: National Institutes of Health.

15.

Putnam

K.P.

, Bombick

D.W.

, & Doolittle

D.J.

(2002). Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicology in Vitro 16, 599–607.

16.

Fukano

, Ogura

, Eguchi

, Shibagaki

, & Suzuki

(2004). Modified procedure of a direct in vitro exposure system for mammalian cells to whole cigarette smoke. Experimental Toxicology and Pathology 5, 317–323.